OverviewSuggest Edit

Abbott is a healthcare company specializing in diagnostics, medical devices, nutritionals, and branded generic medicines. It has expertise in glucose monitoring, blood and plasma screening, adult nutrition, pediatric nutrition, remote heart failure monitoring, point of care testing. The company offers a variety of chronic pain devices and heart pumps (LVADs).
TypePublic
Founded1888
HQLake Bluff, IL, US
Websiteabbott.com
Employee Ratings3.9
Overall CultureC+

Latest Updates

Employees (est.) (Dec 2020)109,000(+2%)
Job Openings3,317
Revenue (FY, 2020)$34.6 B(+9%)
Share Price (Jul 2021)$120.8(+3%)

Key People/Management at Abbott

Miles D. White

Miles D. White

Executive Chairman of the Board
Robert B. Ford

Robert B. Ford

President and Chief Executive Officer
Hubert L. Allen

Hubert L. Allen

Executive Vice President, General Counsel and Secretary
Lisa D. Earnhardt

Lisa D. Earnhardt

Executive Vice President, Medical Devices
John F. Ginascol

John F. Ginascol

Executive Vice President, Core Diagnostics
Andrew H. Lane

Andrew H. Lane

Executive Vice President, Established Pharmaceuticals
Show more

Abbott Office Locations

Abbott has offices in Lake Bluff, Alameda, Austin, Des Plaines and in 125 other locations
Lake Bluff, IL, US (HQ)
100 Abbott Park Rd
Alameda, CA, US
1420 Harbor Bay Pkwy
Austin, TX, US
6300 Bee Cave Rd building 2, suite 100
Des Plaines, IL, US
1300 E Touhy Ave
Hollywood, FL, US
4000 Hollywood Blvd #333
Lake Forest, IL, US
100 S Saunders Rd
Show all (148)

Abbott Financials and Metrics

Abbott Revenue

Embed Graph
View revenue for all periods
Abbott's revenue was reported to be $34.61 b in FY, 2020 which is a 8.5% increase from the previous period.
USD

Revenue (Q1, 2021)

10.5b

Gross profit (Q1, 2021)

6.1b

Gross profit margin (Q1, 2021), %

57.9%

Net income (Q1, 2021)

1.8b

EBIT (Q1, 2021)

2.1b

Market capitalization (23-Jul-2021)

214.6b

Closing stock price (23-Jul-2021)

120.8

Cash (31-Mar-2021)

8.1b

EV

225.0b
Abbott's current market capitalization is $214.6 b.
Annual
USDFY, 2018FY, 2019FY, 2020

Revenue

30.6b31.9b34.6b

Revenue growth, %

12%4%8%

Cost of goods sold

12.7b13.2b15.0b

Gross profit

17.9b18.7b19.6b
Quarterly
USDQ1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021

Revenue

7.5b8.0b8.1b7.7b7.3b8.9b10.5b

Cost of goods sold

3.2b3.3b3.4b3.3b3.3b4.0b4.4b

Gross profit

4.4b4.7b4.7b4.4b4.1b4.9b6.1b

Gross profit Margin, %

58%59%58%58%55%55%58%
Annual
USDFY, 2018FY, 2019FY, 2020

Cash

3.8b3.9b6.8b

Accounts Receivable

5.2b5.4b6.4b

Inventories

3.8b4.3b5.0b

Current Assets

14.6b15.7b20.4b
Quarterly
USDQ1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021

Cash

3.0b3.1b4.1b3.4b4.8b4.5b8.1b

Accounts Receivable

5.3b5.5b5.5b5.3b5.1b5.6b6.1b

Inventories

4.1b4.4b4.4b4.6b5.2b5.2b5.4b

Current Assets

14.4b15.2b16.1b15.5b17.2b17.4b21.8b
Annual
USDFY, 2018FY, 2019FY, 2020

Net Income

2.4b3.7b4.5b

Depreciation and Amortization

3.3b3.0b3.3b

Inventories

(514.0m)(593.0m)(493.0m)

Accounts Payable

747.0m1.8b
Quarterly
USDQ1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021

Net Income

672.0m1.7b2.6b564.0m1.1b2.3b1.8b

Depreciation and Amortization

753.0m1.5b2.3b828.0m1.7b2.5b934.0m

Inventories

(286.0m)(540.0m)(730.0m)(437.0m)(987.0m)(838.0m)(537.0m)

Cash From Operating Activities

712.0m1.8b3.7b715.0m2.0b4.1b2.6b
USDFY, 2018

EV/EBIT

39.1 x

EV/CFO

22.7 x

Revenue/Employee

296.9k

Debt/Equity

0.6 x

Debt/Assets

0.3 x

Financial Leverage

2.2 x

P/E Ratio

54.4
Show all financial metrics

Abbott Operating Metrics

FY, 2018FY, 2019FY, 2020

Products

1.5 k1.5 k

New Product Launches

25

Manufacturing Sites

949293

Manufacturing Sites (Cardiovascular and Neuromodulation Products)

252727
Show all operating metrics

Abbott Acquisitions / Subsidiaries

Company NameDateDeal Size
Cephea Valve TechnologiesJanuary 16, 2019
St. Jude MedicalApril 28, 2016$25 b
Kalila MedicalApril 06, 2016
AlereFebruary 02, 2016$5.3 b
Tendyne HoldingsJuly 31, 2015$250 m
VeropharmDecember 12, 2014$305 m
ToperaOctober 29, 2014$250 m
CFR PharmaceuticalsMay 15, 2014$2.9 b
IDEV TechnologiesJuly 15, 2013$310 m
OptiMedicaJuly 15, 2013$400 m
Show more

Abbott Revenue Breakdown

Embed Graph

Abbott revenue breakdown by business segment: 12.4% from Established Pharmaceuticals, 22.1% from Nutritionals, 31.2% from Diagnostics, 34.1% from Medical Devices and 0.2% from Other

Abbott revenue breakdown by geographic segment: 37.6% from United States and 62.4% from International

Human Capital Metrics

Embed Graph
Show all human capital metrics

Abbott Environment, Social & Governance (ESG) Ratings

CSRHub ESG ratingPremium dataset

60-79

out of 100

CSRHub logo

Abbott Online and Social Media Presence

Embed Graph

Abbott Company Culture

  • Overall Culture

    C+

    67/100

  • CEO Rating

    A-

    74/100

  • Compensation

    B-

    67/100

  • Diversity

    C+

    67/100

Learn more on Comparably

Abbott Blogs

Abbott Becomes First Anchor Sponsor of American Diabetes Association's Health Equity Now Initiative to Advance Access to Care and Technology for People with Diabetes

- Abbott is committing $5 million over three years to the American Diabetes Association (ADA) to help close the health disparities gap for underserved diabetes communities, especially people of color and lower-income Americans

Abbott Named Industry Sustainability Leader for the Eighth Year in a Row on the Dow Jones Sustainability Index (DJSI)

- Abbott achieves top industry scores in governance/economic and social performance, earns more than triple the average industry score in its industry sector

Abbott Announces the U.S. Launch of the IonicRF™ Generator for Use in Patients Living With Chronic Pain

-- Radiofrequency ablation is a minimally invasive procedure to deactivate nerves associated with pain for up to one year

Abbott Introduces Next-generation 3D Cardiac Mapping Platform in Europe and Australia

- The EnSite™ X EP System is a new cardiac mapping system designed from electrophysiologist input to optimize cardiac ablation procedures

Abbott Wins Prestigious Prix Galien USA Award for First-of-its-Kind MitraClip™ Device

-- Considered as the industry's equivalent of the Nobel Prize in biopharmaceutical and medical technology research, Prix Galien USA honored MitraClip as the Best Medical Technology for 2020   -- The groundbreaking MitraClip therapy has positively impacted the lives of more than 100,000 people
Show more

Abbott Frequently Asked Questions

  • When was Abbott founded?

    Abbott was founded in 1888.

  • Who are Abbott key executives?

    Abbott's key executives are Miles D. White, Robert B. Ford and Hubert L. Allen.

  • How many employees does Abbott have?

    Abbott has 109,000 employees.

  • What is Abbott revenue?

    Latest Abbott annual revenue is $34.6 b.

  • What is Abbott revenue per employee?

    Latest Abbott revenue per employee is $317.5 k.

  • Who are Abbott competitors?

    Competitors of Abbott include Otricath, Baxter International and Quest Diagnostics.

  • Where is Abbott headquarters?

    Abbott headquarters is located at 100 Abbott Park Rd, Lake Bluff.

  • Where are Abbott offices?

    Abbott has offices in Lake Bluff, Alameda, Austin, Des Plaines and in 125 other locations.

  • How many offices does Abbott have?

    Abbott has 148 offices.